Non-Alcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome: A Systematic Review, Meta-Analysis, and Meta-Regression.

Ramiro Manzano-Nunez,Marta Santana-Dominguez,Jesus Rivera-Esteban,Clara Sabiote,Elena Sena,Juan Bañares,Frank Tacke,Juan M Pericàs

Journal of Clinical Medicine（2023）

引用 4|浏览2

暂无评分

摘要

The prevalence of NAFLD (43%) among PCOS patients is high despite their average young age, with several metabolic and PCOS-specific factors influencing its occurrence. Screening programs may aid in detecting metabolic-associated fatty liver disease and prevent its consequences. Further work is required to establish the burden of liver-related outcomes once NAFLD has progressed in the PCOS population.

查看译文

关键词

metabolic dysfunction associated fatty liver disease,non-alcoholic fatty liver disease,polycystic ovary syndrome,prevalence,risk factors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要